Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Propofol recalled?

Not under an active recall. Propofol was recalled 20 times in the past — all now closed. Most recent: Aug 22, 2022.

Most common reason: Particulate / foreign matter (14 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Propofol. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Propofol recalls on record

none so far in 2026; 20 on record, newest first
Class II · Moderate risk

Diprivan (Propofol)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 63323-269-29 D-1116-2022
Class II · Moderate risk

Diprivan (Propofol)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 63323-269-10 D-1115-2022
Class II · Moderate risk

Propofol Injectable Emulsion

Presence of Particulate Matter: The firm received a complaint of an embedded particulate in the neck of one vial composed primarily of iron.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-30 D-0381-2015
Class I · High risk

Propofol Injectable Emulsion

Presence of Particulate Matter: A glass defect was found on the interior neck of the vial during a retain sample inspection where the glass vial contained visible embedded metallic particulate and free floating metallic particulates were also found in solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-30 D-1547-2014
Class II · Moderate risk

Propofol Injectible Emulsion

Presence of Particulate Matter: Glass defect located on the interior neck of the vial identified glass surface abrasions and visible embedded particulate matter which could result in the potential for small glass flakes or embedded metal particulate to become dislodged into the solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-30 D-1033-2014
Class II · Moderate risk

Propofol Injectable Emulsion

Presence of Particulate Matter: Visible particulate embedded in the glass vial was observed and confirmed in a sample bottle during retain sample inspection.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-30 D-932-2013
Class II · Moderate risk

Propofol Injectable Emulsion

Presence of Particulate Matter; single visible particulate was identified during a retain sample inspection identified as stainless steel

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-24 D-887-2013
Class II · Moderate risk

Propofol Injectable Emulsion

Presence of Particulate Matter: Visible particulate embedded in vials was observed and confirmed in a sample bottle during retain inspection.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-30 D-223-2013
Class II · Moderate risk

Propofol Injectable Emulsion

Presence of Particulate Matter: A single visible particulate was observed and confirmed in sample bottles of the recalled lots during retain inspection.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-30 D-1685-2012
Class II · Moderate risk

Propofol Injectable Emulsion

Presence of Particulate Matter: A single visible particulate was observed and confirmed in a sample bottle during retain inspection.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-24 D-1672-2012
Class II · Moderate risk

Propofol Injectable Emulsion

Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel

Terminated Particulate / foreign matter Hospira, Inc. NDC 0409-4699-30 D-1382-2012